EMEA-001218-PIP01-11 - paediatric investigation plan

Deoxycholic acid

Key facts

• Active Substance:
  Deoxycholic acid
• Therapeutic area:
  Dermatology
• Decision number:
  -
• PIP number:
  EMEA-001218-PIP01-11
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of localised fat deposits
• Route(s) of administration:
  Subcutaneous use
• Contact for public enquiries:

  Kythera Biopharmaceuticals (Europe) Limited

  United Kingdom; Email: [e-mail] ; Tel. [phone]; Fax [phone]

• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  23/03/2012

Decision

P/0054/2012: EMA decision of 23 March 2012 on the granting of a product specific waiver for deoxycholic acid (EMEA-001218-PIP01-11)

AdoptedReference Number: EMA/107390/2012